Osthol, a Coumarin Isolated from Common Cnidium Fruit, Enhances the Differentiation and Maturation of Osteoblasts in vitro
Authors:
- Jian ZhouJZJian Zhou
- Guo-Zheng ChengGCGuo-Zheng Cheng
- Hui-Ping MaHMHui-Ping Ma
- Ke-Ming ChenKCKe-Ming Chen
- 2 July 2011
- journal article
- Published by S. Karger AG in Pharmacology
- Vol. 88 (1-2) , 33-43
Abstract
The effect of osthol on osteoblasts was investigated in primary osteoblastic cells isolated from newborn Wistar rats. Osthol was supplemented into cultured medium at 10–7, 10–6, 10–5 and 10–4 mol/l, respectively. No stimulating effect was found on cell proliferation, but 10–5 mol/l osthol caused a significant increase in alkaline phosphatase (ALP) activity. Osteogenic differentiation markers were examined over a period of time at this concentration, and compared with control cells that were not supplemented with osthol. The results showed that the ALP activity, osteocalcin secretion and calcium deposition level in cells treated with osthol were 1.52, 2.74 and 2.0 times higher, respectively, than in the control cells. Results of ALP histochemical staining and mineralized bone nodule assays both showed that the number and area achieved in osthol-treated cells were 1.53-fold higher than in control cells. The gene expression of the growth and transcription factors basic fibroblast growth factor, insulin-like growth factor I, bone morphogenetic protein 2 (BMP-2), runt-related gene 2 (Runx-2) and osterix, which are associated with bone development, were also investigated. The increase in mRNA expression was 1.94, 1.74, 1.68, 1.83 and 2.31 times, respectively, higher compared to the control. Furthermore, osthol increased the protein expression of p38 mitogen-activated protein kinase (MAPK) and type I collagen. p38MAPK protein and collagen in osthol-treated cells were 1.42 and 1.58 times higher in osthol-treated cells compared to the control. The results of these studies support the conclusion that osthol significantly enhances the osteogenic differentiation of cultured osteoblasts. The results also indicated that osthol could stimulate the osteoblastic differentiation of rat calvarial osteoblast cultures by the BMP-2/p38MAPK/Runx-2/osterix pathway and that osthol may be used as an important compound in the development of new antiosteoporosis drugs.Keywords
This publication has 28 references indexed in Scilit:
- Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitroJournal of Cellular Biochemistry, 2010
- Role of IGFBP2, IGF-I and IGF-II in regulating long bone growthBone, 2005
- Tissue specificity of 8-prenylnaringenin: Protection from ovariectomy induced bone loss with minimal trophic effects on the uterusThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogensThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Epidemiology of osteoporosisJournal of Epidemiology and Biostatistics, 2001
- Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12Molecular and Cellular Biology, 2000
- Epidemiology of Spinal OsteoporosisSpine, 1997
- Regulation of Bone Formation by Bone Morphogenetic Proteins and Other Growth FactorsClinical Orthopaedics and Related Research, 1996
- The worldwide problem of osteoporosis: Insights afforded by epidemiologyBone, 1995
- Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal womenArchives of internal medicine (1960), 1989